Results 11 to 20 of about 175,446 (337)

Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019

open access: yesAmerican Society of Nephrology. Clinical Journal, 2022
Visual Abstract Background CKD is becoming a major human health concern. Limited quantitative assessments of the burden of CKD due to glomerulonephritis have been performed.
Ju-Lan Hu   +8 more
semanticscholar   +1 more source

Glomerulonephritis: immunopathogenesis and immunotherapy

open access: yesNature reviews. Immunology, 2023
‘Glomerulonephritis’ (GN) is a term used to describe a group of heterogeneous immune-mediated disorders characterized by inflammation of the filtration units of the kidney (the glomeruli).
H. Anders   +3 more
semanticscholar   +1 more source

Introduction to the PANLAR Guidelines: Giant Cell Arteritis

open access: yesGlobal Rheumatology, 2022
Introduction to the PANLAR Guidelines: Giant Cell Arteritis Dr. Sebastián Unizony describes how the process of construction and consolidation of this document by a team of experts was.
Sebastian Unizony
doaj   +1 more source

Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders

open access: yesBMC Women's Health, 2021
Background Consequences of long-term B cell depletion with rituximab are not well understood. We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment, distinct from previously described vulvovaginal pyoderma ...
Laura Yockey   +8 more
doaj   +1 more source

Antineutrophil Cytoplasmic Autoantibody-Negative Pauci-Immune Crescentic Glomerulonephritis in a Patient with Systemic Lupus Erythematosus

open access: yesCase Reports in Nephrology and Dialysis, 2022
Renal involvement in systemic lupus erythematosus is usually exhibited as lupus nephritis, which is a form of immune complex-mediated glomerulonephritis and one of the most severe organ manifestations of systemic lupus erythematosus.
Chee Eng Chan   +3 more
doaj   +1 more source

Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis

open access: yesRMD Open, 2023
Objective To assess outcomes in giant cell arteritis (GCA) patients during and after long-term tocilizumab (TCZ) treatment.Methods Retrospective analysis of GCA patients treated with TCZ at a single centre (2010–2022).
Sebastian H Unizony   +4 more
doaj   +1 more source

The classification of glomerulonephritis in systemic lupus erythematosus revisited.

open access: yesKidney International, 2004
The currently used classification reflects our understanding of the pathogenesis of the various forms of lupus nephritis, but clinicopathologic studies have revealed the need for improved categorization and terminology.
J. Weening   +22 more
semanticscholar   +2 more sources

Incidence rate of and risk factors for glomerulonephritis in patients with axial spondyloarthritis: a nationwide population-based study. [PDF]

open access: yesTher Adv Musculoskelet Dis
Background: Although extramusculoskeletal manifestations, such as uveitis and psoriasis, in patients with axial spondyloarthritis (SpA) are well-documented, studies on the occurrence of glomerulonephritis in this population are scarce.
Hwang S, Kim YJ, Ahn SM, Koo BS.
europepmc   +2 more sources

Crescentic Glomerulonephritis

open access: yesDefinitions, 2020
A histopathologic term for a pattern of diseases characterized by extensive crescent formation in the glomeruli; patients present clinically with rapid deterioration of renal function, and possible progression to end-stage renal failure within weeks or ...

semanticscholar   +1 more source

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

open access: yesKidney International Reports, 2018
Remission induction in antineutrophil cytoplasmic autoantibody (ANCA) vasculitis may be complicated by slow response to treatment and toxicity from glucocorticoids.
Frank B. Cortazar   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy